Ischemic stroke is the second leading cause of death and a major cause of disability. Avilex Pharma investigates a novel principle in treatment to meet this major unmet medical need.
Looking for a particular Avilex Pharma ApS employee's phone or email?
The Avilex Pharma ApS annual revenue was $5.4 million in 2026.
Ian Laquian is the Chief Business Officer of Avilex Pharma ApS.
1 people are employed at Avilex Pharma ApS.
Avilex Pharma ApS is based in København N, Capital Region.
The NAICS codes for Avilex Pharma ApS are [32541, 3254, 32, 325].
The SIC codes for Avilex Pharma ApS are [28, 283].